ICMR funded research project on Plasmodium vivax genomics under the Medical Innovation Fund (2016-2019)
Indo-Canadian (IC-IMPACTS) funded research project on point-of-care assay for malaria diagnosis and drug-resistance genotyping (Canadian PI: Dr. Stephanie Yanow)
NIH funded project on Centre for Study on the Complex malaria in India (CSCMi); US PI: Prof. Jane carlton
DST funded research project on P. falciparum proteomics (PI: Dr. P. Acharya, AIIMS, New Delhi)
Efficacy and safety of artemether-lumefantrine (AL) combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in 4 Tribal dominating states in India: Madhya Pradesh, Maharashtra, Chhattisgarh and Odisha. WHO, Apr -Dec- 2017.
An assessment of intervention measures for prevention of malaria in pregnancy: A prospective longitudinal study in Central India. Indian Council of Medical Research (ICMR) India, July 2015 –Dec 2017.
Setting up of Tribal Health Research Unit at Jagdalpur, Chhattisgarh. Indian Council of Medical Research (ICMR) India, Sep 2013 – Aug 2018.
Study on HRP2 and HRP3 gene in plasmodium falciparum parasite from Odisha states India: A prospective evaluation. Tata Trust, April 2017 –Mar 2018.
Phase III evaluation of Deltamethrin 62.5 SC-PE long lasting indoor residual spraying against An. culicifacies, the vector of malaria in India. Funding: ICMR (Bayer Crop Science), 2017-18.
Bionomics of Malaria Vector - sibling species composition and to establish their role in malaria transmission in Madhya Pradesh. Funding: ICMR Taskforce, 2017-18.
Monitoring of insecticide resistance in malaria vectors in Madhya Pradesh state. Funding: ICMR Taskforce, 2017-18.
Malaria elimination in Mandla district of Madhya pradesh (A public-private-partnership (ppp) project. Funding: Sun Pharmaceutical Industries Limited, 2017-22.
Study on HRP2 and HRP3 gene in Plasmodium falciparum parasites from 8 endemic districts in Odisha: A prospective evaluation, 2017-18. Funding Tata Trust.
Targeted Intervention to expend and strengthen TB control in tribal population under revised National TB control Programme, India.
Intensified Tuberculosis Control among Saharia tribe of M.P. District Guna.
Comparative study of line probe assay and Xpert MTB/RIF for detection of MDR (Funded by ICMR, New Delhi).
Designing a immunovisual assay for early detection of M. tuberculosis from culture (Funded by TATA Trusts, Mumbai).
To design and develop high sensitivity detection of MTB-antigens using Immuno-LAMP to detect Mycobacterium tuberculosis antigens directly from specimens/sputum (Funded by International Society for Infectious Diseases, Brooklyn, USA)
Health systems preparedness for interventions for Non-communicable diseases and cause of death among the tribal population in India:ICMR Task Force Project (Division of NCD).
Intervention Programme for the Management of Scabies - Baiga Tribe of Dindori district of Madhya Pradesh.
Prevalence of Fluorosis in The Community of Selected Districts of India and Development of an Appropriate Intervention Model For Prevention and Control of Fluorosis (Multi-Centric ICMR Taskforce Study).
Screening of hemoglobinopathies in Madhya Pradesh.
Pilot Validation Studies of a new sickle cell diagnostic device- Sickle SCAN® under Indian Condition.
Micro mapping of G6PD deficiency among the tribals of India and its importance for antimalarial therapy.
Screening for G6PD deficiency among the tribal populations living in Malaria endemic zones and its correlation with anti-malarial therapy.
Screening of Hemoglobinopathies in Narsingpur District with special reference to alpha haemoglobin chain variants.
Evaluation of paper based screening test for Sickle cell anemia
Establishment of grade II virology laboratory funded by Indian Council of Medical Research, New Delhi (Ongoing since 2012).
Pilot study on evaluation of rapid diagnostic test kit for dengue in tribal- rural areas of Madhya Pradesh, funded by Department of Health and Family welfare, Govt. of MP. (Ongoing since September 2016).
Enhancing Biorisk mitigation awareness in public health community and creating laboratory networks for enhanced diagnostic capabilities to deal with surveillance and outbreaks of high-risk group viral pathogens causing viral hemorrhagic fevers and respiratory infections funded by NIV Pune/CDC USA. (Ongoing since September 2016).
Apex Referral Laboratory for Dengue and Chikungunya for MP and CG funded by National Vector Borne Disease control Program, New Delhi (Service Project Ongoing since April 2011).
A Multi-Centric Study to estimate the sero-prevalence of dengue virus infection in India (Short term project for four months Sept 2017 to Dec. 2017)
